Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk
- 1 May 1993
- journal article
- Published by Elsevier in The Lancet
- Vol. 341 (8853), 1116-1119
- https://doi.org/10.1016/0140-6736(93)93128-n
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancerVirology, 1992
- Recent Progress in Defining the Epidemiology of Human Papillomavirus Infection and Cervical NeoplasiaJNCI Journal of the National Cancer Institute, 1992
- Human Papillomavirus Infection of the CervixObstetrics & Gynecology, 1992
- Herpes simplex virus type 2: A possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancerInternational Journal of Cancer, 1991
- ARTICLESJNCI Journal of the National Cancer Institute, 1991
- Role of Epidemiology in Defining Events That Influence Transmission and Natural History of Anogenital Papillomavirus InfectionsJNCI Journal of the National Cancer Institute, 1991
- Multiple infections in cases of cervical cancer from a high‐incidence area in tropical AfricaInternational Journal of Cancer, 1989
- Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection.Journal of Clinical Pathology, 1977